Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Novoray Corporation (688300.SS)
Lianyungang, CN
Novoray Corporation is a global enterprise specializing in the research, development, production, and sale of advanced industrial powder materials. Its comprehensive product portfolio encompasses a diverse array of specialized powders, including various forms of silica such as crystalline, fused, soft composite, round corner, spherical, and sub-micron spherical types, alongside spherical aluminum oxide and acicular powder. These high-performance materials cater to a wide spectrum of manufacturing sectors globally, including electronic components, electrical insulation, ceramics, precision casting, paints and coatings, silicon and functional rubbers, plastics, and building materials. Established in 1984, Novoray Corporation maintains its headquarters in Lianyungang, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +16.56% | +21.74% | +20.31% | +78.32% | +89.89% | +80.38% | +162.42% | +246.64% | +451.72% | +614.74% | +614.74% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+16.2% ★ Q1'26: +23.2% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+16.4% ★ Q1'26: +15.4% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+16.3% Q1'26: -11.3% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+30.0% ★ Q1'26: +28.5% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+26.6% ★ Q1'26: +18.2% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-0.1% Q1'26: -0.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.71× ★ Q1'26: 2.07× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
404.20M
est: 424.00M (-4.7%)
|
624.71M
est: 627.28M (-0.4%)
|
661.95M
est: 674.00M (-1.8%)
|
711.68M
est: 840.93M (-15.4%)
|
960.36M
est: 961.01M (-0.1%)
|
1.12B
est: 1.21B (-7.7%)
|
1.48B
1.48B – 1.48B
+22.6% YoY
|
1.82B
1.82B – 1.82B
+22.6% YoY
|
2.09B
2.09B – 2.09B
+15.1% YoY
|
| EBITDA |
144.99M
est: 132.70M (+9.3%)
|
220.82M
est: 196.32M (+12.5%)
|
231.78M
est: 210.94M (+9.9%)
|
249.32M
est: 294.99M (-15.5%)
|
340.66M
est: 337.11M (+1.1%)
|
385.19M
est: 423.78M (-9.1%)
|
519.66M
519.66M – 519.66M
+22.6% YoY
|
636.89M
636.89M – 636.89M
+22.6% YoY
|
732.81M
732.81M – 732.81M
+15.1% YoY
|
| EBIT |
128.73M
est: 111.10M (+15.9%)
|
197.89M
est: 164.37M (+20.4%)
|
195.42M
est: 176.61M (+10.7%)
|
199.66M
est: 251.24M (-20.5%)
|
289.70M
est: 287.12M (+0.9%)
|
334.23M
est: 360.93M (-7.4%)
|
442.59M
442.59M – 442.59M
+22.6% YoY
|
542.43M
542.43M – 542.43M
+22.6% YoY
|
624.12M
624.12M – 624.12M
+15.1% YoY
|
| Net Income |
110.92M
est: 85.98M (+29.0%)
|
172.87M
est: 137.69M (+25.5%)
|
188.24M
est: 144.32M (+30.4%)
|
173.99M
est: 286.03M (-39.2%)
|
251.37M
est: 248.92M (+1.0%)
|
292.64M
est: 382.13M (-23.4%)
|
462.75M
462.75M – 462.75M
+21.1% YoY
|
626.40M
626.40M – 626.40M
+35.4% YoY
|
708.64M
708.64M – 708.64M
+13.1% YoY
|
| SGA |
36.82M
est: 33.64M (+9.4%)
|
46.67M
est: 49.78M (-6.2%)
|
52.57M
est: 53.48M (-1.7%)
|
59.18M
est: 54.96M (+7.7%)
|
65.68M
est: 62.81M (+4.6%)
|
23.59M
est: 78.96M (-70.1%)
|
96.83M
96.83M – 96.83M
+22.6% YoY
|
118.67M
118.67M – 118.67M
+22.6% YoY
|
136.54M
136.54M – 136.54M
+15.1% YoY
|
| EPS |
0.46
est: 0.46 (-0.6%)
|
0.72
est: 0.74 (-2.9%)
|
0.78
est: 0.78 (+0.4%)
|
0.72
est: 1.18 (-39.1%)
|
1.04
est: 1.03 (+1.0%)
|
1.21
est: 1.58 (-23.4%)
|
1.91
1.91 – 1.91
+21.1% YoY
|
2.59
2.59 – 2.59
+35.4% YoY
|
2.93
2.93 – 2.93
+13.1% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | B | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-11 | B | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-08 | B | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-07 | B | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-06 | B | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-30 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | B | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-27 | B | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C+ | 2/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 339.8K | 0.39% |
| 2 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 349.7K | 0.29% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jiakai Cao | Deputy GM & Director | — | male |
| Li Sheng Fan | Accounting Supervisor | — | — |
| Lin Bo | Secretary | — | female |
| Xiaodong Li | Chairman & GM | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 688300.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
